483
Shilpa Pharma Lifesciences LimitedShilpa Pharma Lifesciences Limited – FDA 483, Mar 7, 2025
Record Details
An FDA inspection of Shilpa Pharma Lifesciences Limited, an API non-sterile drug substance manufacturer in Deosugur, revealed significant deficiencies in their Quality Control unit. The firm repeatedly failed to ensure QC personnel followed approved testing procedures, leading to over one hundred human errors since January 2022. Corrective actions, including retraining, have proven ineffective in addressing these persistent issues.
View Company Profile
ID · 42ddd310-1e39-40d2-9c94-bc5f9e569e01
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.